Last month, several college conferences, the Big Ten and the Pac 12 among them, postponed their sports seasons, including football, citing the risks posed to athletes by the coronavirus. A major factor in those decisions, according to some physicians, was the uncertain implications of a July paper in JAMA Cardiology. In this study of 100…
New research presented at this week’s ESCMID Conference on Coronavirus Disease (ECCVID, online 23-25 September) suggests that, as lockdown took effect and case numbers dropped, the amount of virus patients were exposed to (viral load) fell, and this could be linked to lower proportions of patients requiring intensive care and dying. The study is by…
A US study from the city of Detroit, presented at this week’s ESCMID Conference on Coronavirus Disease (ECCMID, online 23-25 September) shows that the initial SARS-CoV-2 viral load in nasopharyngeal samples has been decreasing as the pandemic progressed. The authors also observed that the decline in viral load was associated with a decrease in death…
New research presented at this week’s ESCMID Conference on Coronavirus Disease (ECCVID, online 23-25 September) confirms that men with COVID-19 have worse outcomes than women, possibly related to them experiencing higher levels of inflammation. The study is by Dr Frank Hanses, University Hospital Regensburg, Germany, and colleagues, and shows that men have a 62% increased…
New research presented at this week’s ESCMID Congress on Coronavirus Disease (ECCVID, held online 23-25 September) shows that outbreaks of COVID-19 in elderly care homes were caused by multiple independent infections from outside, plus within care home spread. There is also evidence of transmission between residents and healthcare workers, including paramedics, possibily linking care home…
Two nationwide COVID-19 antibody seroprevalence studies from Brazil show that many cities along the Amazon were hit hardest at the beginning of the epidemic in May and June, along with poorer and Indigenous communities. The research is presented at this week’s ESCMID Conference on Coronavirus Disease (ECCVID, held online 23-25 September) and published in The…
The cover for issue 38 of Oncotarget features Figure 3, “Summary of the time and cost for drug development (modified from DiMasi et al [2016],” by Katayama, et al. which reported that Pancreatic cancer is the most aggressive common cancer and is desperately in need of novel therapies. In this study, the Oncotarget authors perform…
DALLAS (September 23, 2020) – Researchers at Center for BrainHealth, part of The University of Texas at Dallas, collaborated with scientists at the University of North Carolina at Chapel Hill to examine whether the Strategic Memory Advanced Reasoning Training (SMART) program affects people’s abilities to make informed decisions about their medical treatment options. Patients with…
Researchers at the University of Alberta have discovered a novel, second mechanism of action by the antiviral drug remdesivir against SARS-CoV-2, according to findings published today in the Journal of Biological Chemistry. The research team previously demonstrated how remdesivir inhibits the COVID-19 virus’s polymerase or replication machinery in a test tube. Matthias Götte, chair of…
A neighborhood’s overall socioeconomic status, including income and education level, may influence its residents’ risk of chronic kidney disease, according to a study recently published in SSM Population Health by researchers from Drexel University’s Dornsife School of Public Health. Although previous studies have shown an association between individual socioeconomic status and chronic kidney disease, less…